NUTRIREA2Early Enteral vs. Intravenous Nutrition Impact on Mortality in Critically Ill Patients
This study aims to compare the impact of early enteral nutrition (feeding through a tube) versus intravenous nutrition on mortality in critically ill patients.
Nutrition Through Veins
+ Feeding through the digestive system
Iatrogenic Disease+7
+ Infections
+ Pathologic Processes
Prevention Study
Summary
Study start date: March 1, 2013
Actual date on which the first participant was enrolled.This study focuses on critically ill patients who need mechanical ventilation and vasoactive drugs. The main goal is to compare two methods of providing nutrition early on: through the vein (intravenous) and through the digestive system (enteral). The researchers believe that enteral nutrition might lead to a lower risk of death within 28 days, potentially improving the care for these patients. During the study, participants receive either intravenous or enteral nutrition. The primary outcome measured is mortality within 28 days. This helps determine which method of nutrition support is more effective for this specific patient population.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.2410 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Group II
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 41 locations
CHU d'Angers
Angers, FranceCentre hospitalier d'Annecy
Annecy, FranceCentre Hospitalier de Beauvais
Beauvais, France